Delhi New: The third reinforcement dose of the Covid vaccine is still in the stage of scientific ideas and the focus is currently vaccaming the priority population, the government said when India passed another milestone by giving more than 36 doses of crores until 7pm.
“The booster dose is still at the stage and efficacy of scientific ideas is not proven,” said Director General of Indian Medical Research (ICMR) Balram Bhargava.
Research also occurs to investigate how long the antibodies induced by vaccines survive, said Bhargava.
Some studies show that antibodies in patients who recover from Covid-19 can remain for seven to 12 months but there is no clarity in the vaccine induced antibodies, he added.
At present, the government tries to increase vaccination coverage.
GOVT: Study the efficacy of the third vaccine dose
